These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12056715)

  • 1. Acute transient encephalopathy after paclitaxel infusion: report of three cases.
    Ziske CG; Schöttker B; Gorschlüter M; Mey U; Kleinschmidt R; Schlegel U; Sauerbruch T; Schmidt-Wolf IG
    Ann Oncol; 2002 Apr; 13(4):629-31. PubMed ID: 12056715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute transient encephalopathy after weekly paclitaxel infusion.
    Muallaoğlu S; Koçer M; Güler N
    Med Oncol; 2012 Jun; 29(2):1297-9. PubMed ID: 21618057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient encephalopathy after paclitaxel (Taxol) infusion.
    Perry JR; Warner E
    Neurology; 1996 Jun; 46(6):1596-9. PubMed ID: 8649555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute encephalopathy after infusion of paclitaxel].
    Lachkar S; Bota S; Nouvet G; Thiberville L
    Rev Mal Respir; 2006 Feb; 23(1 Pt 1):73-7. PubMed ID: 16604029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute encephalopathy: a new toxicity associated with high-dose paclitaxel.
    Nieto Y; Cagnoni PJ; Bearman SI; Shpall EJ; Matthes S; DeBoom T; Barón A; Jones RB
    Clin Cancer Res; 1999 Mar; 5(3):501-6. PubMed ID: 10100699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.
    Tsavaris N; Polyzos A; Kosmas C; Giannikos L; Gogas J
    Cancer Chemother Pharmacol; 1997; 40(4):353-7. PubMed ID: 9225955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.
    Rook J; Rosser T; Fangusaro J; Finlay J
    Pediatr Blood Cancer; 2008 Mar; 50(3):699-700. PubMed ID: 16991134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible life-threatening encephalopathy in the absence of hepatic failure following conventional doses of docetaxel.
    Guglani S; Farrugia D; Elsdon M; Parmar M; Owen JR
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):160-1. PubMed ID: 12801056
    [No Abstract]   [Full Text] [Related]  

  • 9. One-hour paclitaxel via weekly infusion: dose-density with enhanced therapeutic index.
    Seidman AD
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):19-22. PubMed ID: 9516598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient encephalopathy after Taxol infusion.
    Walz R; Muxfeldt Bianchin M; Kliemann F
    Neurology; 1997 Oct; 49(4):1188-9. PubMed ID: 9339733
    [No Abstract]   [Full Text] [Related]  

  • 11. Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines.
    Gianni L; Munzone E; Capri G; Villani F; Spreafico C; Tarenzi E; Fulfaro F; Caraceni A; Martini C; Laffranchi A
    J Natl Cancer Inst; 1995 Aug; 87(15):1169-75. PubMed ID: 7674322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.
    Zimmerman TM; Grinblatt DL; Malloy R; Williams SF
    Cancer; 1998 Oct; 83(8):1540-5. PubMed ID: 9781947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer.
    Tolcher AW
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):37-43. PubMed ID: 8629035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of severe acute hypersensitivity reactions after rapid paclitaxel infusion of less than 1-h duration.
    Tsavaris NB; Kosmas C
    Cancer Chemother Pharmacol; 1998; 42(6):509-11. PubMed ID: 9788579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
    Langer CJ; Millenson M; O'Dwyer P; Kosierowski R; Alexander R; Litwin S; McAleer CA; Bonjo CA; Ozols R
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phase I study with one-hour paclitaxel infusion.
    Mross K; Hauns B; Häring B; Bauknecht T; Meerpohl HG; Unger C; Maier-Lenz H
    Ann Oncol; 1998 May; 9(5):569-72. PubMed ID: 9653500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.
    Schwartsmann G; Mans DR; Menke CH; Xavier N; Caleffi M; Ferreira Filho AF; Schunemann H; Kalakun L; Koya R; Pohlman P; Venegas LF
    Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):24-9. PubMed ID: 9144687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Weekly paclitaxel therapy for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.